| Title | Presenting Author | Presentation | Location |
|---|---|---|---|
| Allergen immunotherapy in the BRIT Registry | Rachel Baigel | Poster walk B, Friday 11:00 – 11:45 | A169 |
| Assessment of return rates for patient related outcome measures (PROM) in the BSACI Registry for Immunotherapy (BRIT) | Mich Lajeunesse | Poster walk B, Friday 11:00 – 11:45 | A168 |
| A summary of data held by the BSACI Registry for Immunotherapy (BRIT) for the diagnosis, and treatment of Chronic Spontaneous Urticaria (CSU) using Omalizumab (MAB) | Stefanny Achunche | Poster walk B, Friday 11:00 – 11:45 | A033 |
| The BRIT Report 2025: a summary of data held by the BSACI Registry for Immunotherapy (BRIT) | Mich Lajeunesse | Poster walk B, Friday 11:00 – 11:45 | A167 |
| Real-World Insights into Venom Immunotherapy in the United Kingdom: Analysis from the BSACI Registry For Immunotherapy (BRIT) | Leyla Pur | Poster walk B, Friday 11:00 – 11:45 | |
| Peanut Immunotherapy viewed from the BRIT registry | Rosalynd Gourgey | Poster walk A, Thursday 15:30 – 16:15 | A072 |